EUVIMEDEUVIMED entdecken
Crossref

The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation

Irene Lepori iD, Kiserian Jackson, Zichen Liu iD, Mahendra D Chordia, Mitchell Wong, Sylvia L Rivera, Marta Roncetti, Laura Poliseno iD, Joel S Freundlich, Marcos M Pires iD, M Sloan Siegrist iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.4c01062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Irene Lepori und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Massachusetts, Amherst, Massachusetts 01003, United States. Hauptthemen laut MEDLINE: Mycobacterium smegmatis, Anti-Bacterial Agents, Mycobacterium tuberculosis, Cell Wall. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: NIAID NIH HHS, Associazione Italiana per la Ricerca sul Cancro, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium smegmatisAnti-Bacterial AgentsMycobacterium tuberculosisCell WallCell MembranePeptidoglycanVancomycin

Stichwörter der Autor:innen

antibioticsbioorthogonal click chemistrycell envelopepermeabilitytuberculosis

Substanzen

Anti-Bacterial AgentsPeptidoglycanVancomycin

Autor:innen und Institutionen

  • Department of Microbiology, University of Massachusetts, Amherst, Massachusetts 01003, United States.
  • Molecular and Cellular Biology Program, University of Massachusetts, Amherst, Massachusetts 01003, United States.
  • Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
  • Department of Microbiology, Immunology, and Cancer, University of Virginia, Charlottesville, Virginia 22904, United States.
  • Institute of Clinical Physiology, National Research Council (CNR-IFC), Pisa 56124, Italy.
  • Oncogenomics Unit, Core Research Laboratory, ISPRO, Pisa 56124, Italy.

ORCID-Profile: Irene Lepori, Zichen Liu, Laura Poliseno, Marcos M Pires, M Sloan Siegrist

Förderung

  • NIAID NIH HHS
  • Associazione Italiana per la Ricerca sul Cancro
  • National Institute of Allergy and Infectious Diseases
  • Institute for Applied Life Sciences, University of Massachusetts Amherst
  • Gates Family Foundation
  • NextGenerationEU
  • ISPRO-Istituto per lo Studio, la Prevenzione e la Rete Oncologica

Zitieren

APA

Lepori, I., Jackson, K., Liu, Z., Chordia, M. D., Wong, M., Rivera, S. L., Roncetti, M., Poliseno, L., Freundlich, J. S., Pires, M. M., & Siegrist, M. S. (2025). The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c01062

Vancouver

Lepori I, Jackson K, Liu Z, Chordia MD, Wong M, Rivera SL, et al. The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.4c01062

BibTeX
@article{Lepori2025,
  author = {Lepori, Irene and Jackson, Kiserian and Liu, Zichen and Chordia, Mahendra D and Wong, Mitchell and Rivera, Sylvia L and Roncetti, Marta and Poliseno, Laura and Freundlich, Joel S and Pires, Marcos M and Siegrist, M Sloan},
  title = {The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.4c01062}
}
Kostenlos starten →